Skip to main content

Achieving Risk-Specific Absolute LDL-C Threshold with PCSK9 Inhibitors: A Real-World, Single-Center Analysis Cover

.blurhash-client-img { display: none !important; }

Achieving Risk-Specific Absolute LDL-C Threshold with PCSK9 Inhibitors: A Real-World, Single-Center Analysis

Romanian Journal of Internal Medicine

By: Dana Mihaela Ciobanu, Antonia Berchișan, Cosmina Mălan, Adriana Rusu, Anca-Elena Crăciun, Georgeta Inceu, Diana-Maria Tholvay and Cornelia Bala

Open Access

|Oct 2026

Download Article

Download the full article as a PDF file.

Figures & tables

Articles in this issue

DOI: https://doi.org/10.2478/rjim-2026-0025 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English, Romanian

Submitted on: Sep 4, 2026

|

Published on: Oct 26, 2026

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Keywords:

Hypercholesterolemia,

PCSK9 Inhibitors,

Cardiovascular Diseases,

Treatment Outcome

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2026 Dana Mihaela Ciobanu, Antonia Berchișan, Cosmina Mălan, Adriana Rusu, Anca-Elena Crăciun, Georgeta Inceu, Diana-Maria Tholvay, Cornelia Bala, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article